Business

AngioDynamics Announces Details for Investor & Technology Day on July 13, 2021

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access,

articleAngiodynamics, Inc.July 8, 20215/company/angiodynamics-inc/news/angiodynamics-announces-details-for-investor-technology-day-on-july-13-2021-2021-07
AngioDynamics Announces Details for Investor & Technology Day on July 13, 2021

About this update from Angiodynamics, Inc.

[{"type":"text","content":" LATHAM, N.Y.--(BUSINESS WIRE)--\nAngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will host its Investor & Technology Day on Tuesday, July 13, from 9:30 a.m. to approximately 11:30 a.m. ET, which will include a question-and-answer session.\n\nThe event, to be held virtually, will include presentations from AngioDynamics’ executive leadership team. The Company will provide a detailed overview of its growth strategy and key technology platforms, as well as its financial goals and capital allocation strategy.\n\nAll interested parties may register for the event at the Investor & Technology Day webcast link, which is available on the “Investors” section of the AngioDynamics website at www.angiodynamics.com under “Events & Presentations.”\n\nTo participate via telephone, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international) and refer to the passcode 13720741.\n\nA live webcast of the Investor & Technology Day presentation and related materials will be available on the “Investors” section of the AngioDynamics website at www.angiodynamics.com under “Events & Presentations.” The webcast replay will be archived on the same site shortly after the end of the event.\n\nAbout AngioDynamics, Inc.\n\nAngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. For more information, visit www.angiodynamics.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210708005955/en/\n\nInvestor Contact:\n\nAngioDynamics, Inc.\nStephen Trowbridge, Executive Vice President & CFO\n(518) 795-1408\n\nSource: AngioDynamics, Inc.","length":3977,"tagName":"div"}]

More updates from Angiodynamics, Inc.